Loading...
Header Logo
Keywords
Last Name
Institution

Thomas Lincoln MD

TitleAssociate Professor
InstitutionUMMS - Baystate Regional Campus
DepartmentMedicine at UMMS-Baystate
AddressBaystate Health
380 Plainfield Street
Springfield MA 01107
Phone413-794-4458
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Wesleyan University, Middleton, CT, United StatesBAPhysics
    University of Massachusetts Medical School, Worcester, MA, United StatesMD

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, Altice FL. Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial. J Acquir Immune Defic Syndr. 2018 May 01; 78(1):43-53. PMID: 29373393.
      View in: PubMed
    2. Lincoln T, Johnson BD, McCarthy P, Alexander E. Extended-release naltrexone for opioid use disorder started during or following incarceration. J Subst Abuse Treat. 2018 Feb; 85:97-100. PMID: 28479011.
      View in: PubMed
    3. Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40]. J Subst Abuse Treat. 2017 Jun; 77:44. PMID: 28476270.
      View in: PubMed
    4. Lincoln T, Simon-Levine D, Smith J, Donenberg GR, Springer SA, Zaller N, Altice FL, Moore K, Jordan AO, Draine J, Desabrais M. Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study. J Correct Health Care. 2015 Apr; 21(2):125-39. PMID: 25788608; PMCID: PMC4433291.
    5. Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014 Nov; 39(2):256-68. PMID: 25240704.
      View in: PubMed
    6. Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat. 2014 Jul; 47(1):35-40. PMID: 24674234.
      View in: PubMed
    7. Avery AK, Ciomcia RW, Lincoln T, Desbrais M, Jordan AO, Rana AI, Machekano R. Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study. AIDS Behav. 2013 Oct; 17 Suppl 2:S137-44. PMID: 23054036.
      View in: PubMed
    8. Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013 Oct; 17 Suppl 2:S118-27. PMID: 23673792; PMCID: PMC3818019.
    9. Spaulding AC, Messina LC, Kim BI, Chung KW, Lincoln T, Teixeira P, Avery AK, Cunningham M, Stein MS, Ahuja D, Flanigan TP. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav. 2013 Oct; 17 Suppl 2:S203-11. PMID: 23076719.
      View in: PubMed
    10. Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, Booker CA, Ferguson A, Figueroa H, Lincoln T, Ouellet LJ, Porterfield J, Spaulding AC, Tinsley MJ. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011 Mar; 23(3):366-77. PMID: 21347900.
      View in: PubMed
    11. Lincoln T, Tuthill RW, Roberts CA, Kennedy S, Hammett TM, Langmore-Avila E, Conklin TJ. Resumption of smoking after release from a tobacco-free correctional facility. J Correct Health Care. 2009 Jul; 15(3):190-6. PMID: 19477804.
      View in: PubMed
    12. Joesoef MR, Weinstock HS, Kent CK, Chow JM, Boudov MR, Parvez FM, Cox T, Lincoln T, Miller JL, Sternberg M. Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy. Sex Transm Dis. 2009 Feb; 36(2 Suppl):S67-71. PMID: 19125147.
      View in: PubMed
    13. Gift TL, Lincoln T, Tuthill R, Whelan M, Briggs LP, Conklin T, Irwin KL. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis. 2006 Oct; 33(10 Suppl):S103-10. PMID: 17003677.
      View in: PubMed
    14. Lincoln T, Kennedy S, Tuthill R, Roberts C, Conklin TJ, Hammett TM. Facilitators and barriers to continuing healthcare after jail: a community-integrated program. J Ambul Care Manage. 2006 Jan-Mar; 29(1):2-16. PMID: 16340615.
      View in: PubMed
    15. Lincoln T, Chavez RS, Langmore-Avila E. US experience of smoke-free prisons. BMJ. 2005 Dec 17; 331(7530):1473. PMID: 16356992; PMCID: PMC1315702.
    Lincoln's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description